It is remarkable that adverse drug events are missing in your study results, while falls and drug related AEs were the most frequent ones in the Canadian study. Also other types of adverse events that were listed in table 1 as triggers, such as anxiety, severe worry, are lacking.
I think the following sentence is incorrect: 'The pattern of AEs originating within or outside home health care is similar and may predominately characterize the risks for this group of elderly fragile patients, irrespective of the health care setting. ' The focus was home care and detect some AEs originating from another settings.
To state this, you should set up another design/take another sample of record (records from health care setting outside the home care setting.
Some methodological issues/questions: -Record keeping in home care: I have no clue/insight in the record keeping in home care. Is it electronic or paper based? Who is writing what? What are the responsibilities in record keeping. Where is the record located? -Random sample of 600 patients: how big was the total population and is this sample representative for the total sample of patients/clients who receive home care? -Ten teams for 600 records is a lot. With 5 teams, our review process was more efficient. -10% of the records were reviewed by a second reviewer. What was the inter-rater reliability? -Why using two scales for severity? (NCC MERP Index and HMPS method) - 
GENERAL COMMENTS
The paper is an important study. The record review method is useful to map risk of adverse events in healthcare services. It is good that this method now also is available for home care services. It will be appreciated by many. The paper is well written. It has few but however important flaws that need to be addressed.
1.
To what extent is the sample in this study is representative for the total population of patients with home care services, which the sample has been drawn from. On page 6 lines 55-60 you write that patients with very little home care services were excluded from the study. Please clarify better the criteria for the amount of home care services that patients needed to receive, to be eligible for the study. Please state how many patients with home care services that were randomly drawn, but had to be excluded from the sample because they were not eligible for the study? 2.
The paper does not clarify on what legal and ethical conditions the review and research has been performed. Please do so.
3.
Statistics that inform on margin of error for the estimated percentages, like for example confidence intervals should be stated.
4.
The adjustments to the severity scale (E-I) are well justified and logic.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 A) You used a commonly used method to review records on adverse events and found remarkable results: 37.7% patients experiences an AE, while the incidence in Dutch hospitals is 5.7% (Zegers 2009), in Danish hospitals 9.0% (Schioler 2001) and 12.3% in Swedish hospitals (Soop 2009). So, hospital care is safer than home care?
B) The studies you refer to are based on another record review methodology. There are many similarities between the trigger tool methodology that we have used and the Harvard Medical Practice Study methodology used in the studies mentioned. However, there are also several differences between them which affect the outcome. These differences include the threshold for inclusion of adverse events, the length of the inclusion period, the length of time for primary review, the exclusion of omission (trigger tools), the review process, the details in the descriptions of triggers/screening criteria etc.
Furthermore, the definition of AE differs somewhat. Zegers writes about temporary or permanent disability, death or prolongation of hospital stay. Schioler defines an AE as injury and further that said injury should have prolonged hospital stay or caused outpatient follow-up or disability at discharge. Soop defines an AE as an unintended injury or complication which results in disability at discharge, death or prolongation of hospital stay. Our definition included more transient and minor AEs. Looking at Zegers' study, it reports only 3.7% of AEs in the group nursing care. In our study, we have identified substantially more AEs that could have belonged to this group.
When comparing severe AEs giving moderate (recovery within 6-12 months) or permanent disability or death, by recalculating their respective prevalence, there seem to be no obvious differences between our study and those the reviewer refers to. The same seems true also for comparisons with earlier studies of home health care. We discuss this in the revised version of the text. There are studies from hospital care looking at specific specialties that report figures higher than in those three national studies. From intensive care, 19.5% of patients had an AE (Nilsson 2012), from orthopaedic care, 30.0% (Unbeck, 2013), from paediatric care, 34.0% (Unbeck 2014), and from hospitalized cancer patients, 24.2% (Haukland, 2017) . According to Hibbert 2016, the range of admissions with an AE, for 17 general inpatient (general, general medical, general surgical) studies varied between 7 and 40%, with a cluster of nine studies between 20 and 29%.
A) It is remarkable that adverse drug events are missing in your study results, while falls and drug related AEs were the most frequent ones in the Canadian study. Also other types of adverse events that were listed in table 1 as triggers, such as anxiety, severe worry, are lacking. B) There is, to our knowledge, no commonly accepted and used list of AEs for comparison between studies. The triggers in the medication module point at different types of AEs. We have chosen not to characterize them as a group "adverse drug event," but instead look at the type of injury the patient had and characterize it from that viewpoint.
The cause of a fall or a haemorrhage might have been a drug overdose. As "adverse drug event" is not seldom used as a separate group, we have expanded on this in the discussion.
The trigger including anxiety, worry etc. is referred to as psychological harm in the list of AEs. A) I think the following sentence is incorrect: 'The pattern of AEs originating within or outside home health care is similar and may predominately characterize the risks for this group of elderly fragile patients, irrespective of the health care setting. ' The focus was home care and detect some AEs originating from another settings. To state this, you should set up another design/take another sample of record (records from health care setting outside the home care setting. B) We agree and have deleted this sentence.
A) Record keeping in home care: I have no clue/insight in the record keeping in home care. Is it electronic or paper based? Who is writing what? What are the responsibilities in record keeping. Where is the record located? B) We have added a description in the methods section.
A) Random sample of 600 patients: how big was the total population and is this sample representative for the total sample of patients/clients who receive home care? B) The review was closely connected to the development and validation of a trigger tool for patients admitted to home health care. As written, we recruited the review teams using a convenience strategy. Teams interested in patient safety were asked to participate, and they were integrated in the refinement process of the trigger tool. We aimed for a rich patient material and looked for teams representing "basic" as well as advanced home health care. In 2016, approximately 350,000 individuals received home health care in Sweden. Our ambition was not to have a representative sample from the entire country. We have included the fact that our sample cannot be regarded as representative for patients receiving home health care in Sweden as a limitation of the study.
A) Ten teams for 600 records is a lot. With 5 teams, our review process was more efficient. B) As home healthcare is organized differently in different municipalities and regions, we wanted to capture records from many places across the country -and therefore we chose to include all teams that volunteered. Additionally, the review teams interacted in a Delphi process for the development and validation of triggers suited for home health care. By having ten teams we gained more input on the triggers. We also faced some problems in recruiting teams as managers were reluctant to give "time off" for reviews. Ten teams made the work load more acceptable.
A) 10% of the records were reviewed by a second reviewer. What was the inter-rater reliability? B) The inter-rater reliability of the primary reviewers' judgements concerning if a record was to be forwarded to secondary review was κ = 0.801 (substantial). We now include this figure and have changed the reporting of percentage agreement.
A) Why using two scales for severity? (NCC MERP Index and HMPS method) B) In designing the study we wondered which severity scale would be the most appropriate in this setting. As can be seen in Table 4 , the HMPS scale appeared less appropriate. We have added a discussion explaining the use of two scales. A) Table 5 : 'adverse drug event' is missing as AE type. B) We did not use "adverse drug event" as an AE type. Instead we categorized the harm that was caused by a drug AE, for example fall, haemorrhage, constipation. Allergic reaction is shown in Table  5 .
Reviewer 2 A) To what extent is the sample in this study representative for the total population of patients with home care services, which the sample has been drawn from. B) We did not use a stratified sample of records for the total number of patients receiving home health care in Sweden. Our review was closely intergraded in a development and validation process for a trigger tool adjusted for home health care. However, the records were randomly chosen from the ten reviewing sites. We have added this information in the revised text.
A) On page 6 lines 55-60 you write that patients with very little home care services were excluded from the study. Please clarify better the criteria for the amount of home care services that patients needed to receive, to be eligible for the study. Please state how many patients with home care services that were randomly drawn, but had to be excluded from the sample because they were not eligible for the study? B) We agree that this is a limitation. Regrettably, this exclusion criterion was not defined in a more precise manner than by examples of very sparse care interventions. We compare this exclusion criterion to the GTT criterion of excluding hospital stays less than 24 hours. Those figures are not displayed. We did not identify the numbers of records that were excluded. In a future handbook, this exclusion criterion needs a strict definition, for instance "no more than one assistance per week." We have added this as a limitation of the study.
A) The paper does not clarify on what legal and ethical conditions the review and research has been performed. Please do so. B) We have added this information.
